1.聊城市第二人民医院麻醉科,山东 聊城 252600
2.青岛大学附属医院麻醉科,山东 青岛 266000
3.聊城市第二人民医院神经外科,山东 聊城 252600
Received:18 September 2025,
Published:25 May 2026
移动端阅览
吕文静,唐润栋,刘昆等.瑞芬太尼对脑胶质瘤细胞恶性生物学行为的影响机制研究[J].局解手术学杂志,2026,35(05):407-413.
LYU Wen-jing,TANG Run-dong,LIU Kun,et al.Research on the mechanism of remifentanil on the malignant biological behaviors of glioma cells[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2026,35(05):407-413.
吕文静,唐润栋,刘昆等.瑞芬太尼对脑胶质瘤细胞恶性生物学行为的影响机制研究[J].局解手术学杂志,2026,35(05):407-413. DOI: 10.11659/jjssx.09E025070.
LYU Wen-jing,TANG Run-dong,LIU Kun,et al.Research on the mechanism of remifentanil on the malignant biological behaviors of glioma cells[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2026,35(05):407-413. DOI: 10.11659/jjssx.09E025070.
目的
2
探讨瑞芬太尼对脑胶质瘤细胞恶性生物学行为的影响及可能机制。
方法
2
用0、0.5、1.0、2.0、4.0、8.0 mg/mL瑞芬太尼处理脑胶质瘤细胞U87 MG,CCK-8检测细胞活性,计算
IC
50
;将U
87 MG细胞分为对照组(Control组)、瑞芬太尼组(Remifentanil组)、瑞芬太尼+Jagged-1/Notch信号通路激活剂组(Remifentanil+Jagged-1组)、Jagged-1/Notch信号通路抑制剂组(DAPT组)、瑞芬太尼+Jagged-1/Notch信号通路抑制剂组(Remifentanil+DAPT组);细胞克隆实验检测细胞增殖能力;流式细胞术检测细胞凋亡情况;Western blot检测细胞增殖、凋亡、上皮间质转化(EMT)及Jagged-1/Notch信号通路相关蛋白表达。建立裸鼠移植瘤模型,分析瑞芬太尼对移植瘤生长及Jagged-1/Notch信号通路相关蛋白表达的影响;免疫组化检测瘤组织增殖、凋亡、EMT相关蛋白表达。
结果
2
与Control组比较,Remifentanil组和DAPT组细胞克隆数减少(
P
0.05),Ki67、PCNA、Snail、N-cadherin、Vimentin、Jagged-1、Notch1、Hes1蛋白表达降低(
P
0.05),细胞凋亡率、Bax、C-caspase-3表达升高(
P
0.05);与Remifentanil组比较,Remifentanil+Jagged-1组细胞克隆数增加(
P
0.05),Ki67、PCNA、Snail、N-cadherin、Vimentin、Jagged-1、Notch1、Hes1表达升高(
P
0.05),细胞凋亡率,Bax、C-caspase-3蛋白表达降低(
P
0.05);与Remifentanil组和DAPT组比较,Remifentanil+DAPT组细胞克隆数减少(
P
0.05),Ki67、PCNA、Snail、N-cadherin、Vimentin、Jagged-1、Notch1、Hes1蛋白表达降低(
P
0.05),细胞凋亡率,Bax、C-caspase-3蛋白表达升高(
P
0.05)。裸鼠移植瘤实验结果显示,与NC组比较,REM组移植瘤体积、瘤质量及Jagged-1、Notch1、Hes1、Ki67、PCNA、Snail、N-cadherin和Vimentin表达降低(
P
0.05),Bax、C-caspase-3表达升高(
P
0.05)。
结论
2
瑞芬太尼可抑制脑胶质瘤细胞的增殖及EMT,并促进其凋亡,该作用与抑制Jagged-1/Notch信号通路相关。
Objective
2
To investigate the effects of remifentanil on malignant biological behaviors of glioma cells and its potential mechanism.
Methods
2
U87 MG glioma cells were treated with remifentanil at concentrations of 0, 0.5, 1.0, 2.0, 4.0, and 8.0 mg/mL. Cell viability was assessed by CCK-8 assay, and
IC
50
was calculated. U87 MG cells were divided into the Control group, the Remifentanil group, the Remifentanil+Jagged-1/Notch signaling pathway activator group (the Remifentanil+Jagged-1 group), the Jagged-1/Notch signaling pathway inhibitor group (the DAPT group), and the Remifentanil+Jagged-1/Notch signaling pathway inhibitor group (the Remi
fentanil+DAPT group). Cell colony formation assay was used to detect cell proliferation ability. Flow cytometry was used to detect cell apoptosis. Western blot was used to detect the expression levels of proteins related to cell proliferation, apoptosis, epithelial-mesenchymal transition (EMT), and the Jagged-1/Notch signaling pathway. A nude mouse xenograft tumor model was established to evaluate the effects of remifentanil on tumor growth and the expression levels of proteins related to Jagged-1/Notch signaling pathway. Immunohistochemistry was used to detect the expression levels of proliferation, apoptosis, and EMT-related proteins in tumor tissues.
Results
2
Compared with the Control group, the number of cell colonies and the expression levels of Ki67, PCNA, Snail, N-cadherin, Vimentin, Jagged-1, Notch1 and Hes1 proteins in both the Remifentanil group and the DAPT group were decreased (
P
0.05), while the apoptosis rate and the expression levels of Bax and C-caspase-3 proteins were increased (
P
0.05). Compared with the Remifentanil group, the number of cell colonies and the expression levels of Ki67, PCNA, Snail, N-cadherin, Vimentin, Jagged-1, Notch1 and Hes1 proteins in the Remifentanil+Jagged-1 group were increased (
P
0.05), while the apoptosis rate and the expression levels of Bax and C-caspase-3 proteins were decreased (
P
0.05). Compared with the Remifentanil group and the DAPT group,the number of cell colonies and the expression levels of Ki67,PCNA,Snail,N-cadherin,Vimentin, Jagged-1, Notch1 and Hes1 proteins in the Remifentanil+DAPT group were decreased (
P
0.05), while the apoptosis rate and the expression levels of Bax and C-caspase-3 proteins were increased (
P
0.05). The results of the nude mouse xenograft tumor experiment showed that compared with the NC group, the tumor volume and tumor weight, as well as the expression levels of Jagged-1, Notch1, Hes1, Ki67, PCNA, Snail, N-c
adherin and Vimentin in the REM group were decreased (
P
0.05), while the expression levels of Bax and C-caspase-3 were increased (
P
0.05).
Conclusion
2
Remifentanil inhibits the proliferation and EMT and promotes apoptosis of glioma cells, and this effect is associated with the inhibition of Jagged-1/Notch signaling pathway.
Schaff LR , Mellinghoff IK . Glioblastoma and other primary brain malignancies in adults:a review [J]. JAMA , 2023 , 329 ( 7 ): 574 - 587 . doi: 10.1001/jama.2023.0023 http://dx.doi.org/10.1001/jama.2023.0023 .
Colopi A , Fuda S , Santi S , et al . Impact of age and gender on glioblastoma onset,progression,and management [J]. Mech Ageing Dev , 2023 , 211 ( 1 ): 111801 - 111811 . doi: 10.1016/j.mad.2023.111801 http://dx.doi.org/10.1016/j.mad.2023.111801 .
Wang LM , Englander ZK , Miller ML , et al . Malignant glioma [J]. Adv Exp Med Biol , 2023 , 1405 ( 1 ): 1 - 30 . doi: 10.1007/978-3-031-23705-8_1 http://dx.doi.org/10.1007/978-3-031-23705-8_1 .
Liang W , Ke J . Remifentanil reduces the proliferation,migration and invasion of HCC cells via lncRNA NBR2/miR-650/TIMP3 axis [J]. Int J Exp Pathol , 2022 , 103 ( 2 ): 44 - 53 . doi: 10.1111/iep.12429 http://dx.doi.org/10.1111/iep.12429 .
Ran Y , Han S , Gao D , et al . Interference of FZD2 suppresses proliferation,vasculogenic mimicry and stemness in glioma cells via blocking the Notch/NFκB signaling pathway [J]. Exp Ther Med , 2024 , 28 ( 4 ): 373 - 384 . doi: 10.3892/etm.2024.12662 http://dx.doi.org/10.3892/etm.2024.12662 .
Luo Y , Yu X , Zhao P , et al . Effects of resveratrol on tight junction proteins and the Notch1 pathway in an HT-29 cell model of inflammation induced by lipopolysaccharide [J]. Inflammation , 2022 , 45 ( 6 ): 2449 - 2464 . doi: 10.1007/s10753-022-01704-2 http://dx.doi.org/10.1007/s10753-022-01704-2 .
夏德国 , 颜克实 , 陆大浩 , 等 . 瑞芬太尼抑制人肝癌细胞Notch信号通路及细胞生长的研究 [J]. 实用临床医药杂志 , 2022 , 26 ( 8 ): 32 - 36 . doi: 10.7619/jcmp.20214486 http://dx.doi.org/10.7619/jcmp.20214486 .
李艳 , 侯梓杰 , 阮中繁 . 基于NF-κB iNOS-COX-2信号通路探究瑞芬太尼对脑缺血再灌注损伤大鼠神经功能的作用机制 [J]. 中国老年学杂志 , 2023 , 43 ( 13 ): 3232 - 3235 . doi: 10.3969/j.issn.1005-9202. 2023.13.042 http://dx.doi.org/10.3969/j.issn.1005-9202.2023.13.042 .
邱卫华 , 郭晴晴 , 罗建喜 . 瑞芬太尼通过上调lncRNA DGCR5表达影响卵巢癌细胞增殖和转移的机制研究 [J]. 实用临床医药杂志 , 2023 , 27 ( 16 ): 43 - 49 . doi: 10.7619/jcmp.20231854 http://dx.doi.org/10.7619/jcmp.20231854 .
孙成成 , 刘宇 , 胡旭明 . 瑞芬太尼通过miR-519d-3p/STAT3对胃癌细胞增殖、凋亡的影响 [J]. 世界华人消化杂志 , 2019 , 27 ( 16 ): 984 - 990 . doi: 10.11569/wcjd.v27.i16.984 http://dx.doi.org/10.11569/wcjd.v27.i16.984 .
赵铤 , 赵全丰 , 李坤庆 , 等 . 瑞芬太尼通过调控lncRNA SUMO1P3表达抑制肾癌细胞786-O的增殖、迁移和侵袭 [J]. 山西医科大学学报 , 2021 , 52 ( 11 ): 1396 - 1402 . doi: 10.13753/j.issn.1007-6611.2021.11.003 http://dx.doi.org/10.13753/j.issn.1007-6611.2021.11.003 .
Fu J , Zhu SH , Xu HB , et al . Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway [J]. J Ethnopharmacol , 2020 , 261 ( 1 ): 113071 - 113081 . doi: 10.1016/j.jep.2020.113071 http://dx.doi.org/10.1016/j.jep.2020.113071 .
Zuo J , Liu C , Ni H , et al . WDR34 affects PI3K/Akt and Wnt/ β-catenin pathways to regulates malignant biological behaviors of glioma cells [J]. J Neurooncol , 2022 , 156 ( 2 ): 281 - 293 . doi: 10.1007/ s11060-021-03932-2 http://dx.doi.org/10.1007/s11060-021-03932-2 .
Tian Z , Dai Q , Liu B , et al . LncARSR promotes glioma tumor growth by mediating glycolysis through the STAT3/HK2 axis [J]. Cytokine , 2024 , 180 ( 1 ): 156663 - 156673 . doi: 10.1016/j.cyto.2024.156663 http://dx.doi.org/10.1016/j.cyto.2024.156663 .
Nan Y , Guo L , Zhen Y , et al . miRNA-451 regulates the NF-κB signaling pathway by targeting IKKβ to inhibit glioma cell growth [J]. Cell Cycle , 2021 , 20 ( 19 ): 1967 - 1977 . doi: 10.1080/15384101.2021. 1969496 http://dx.doi.org/10.1080/15384101.2021.1969496 .
Ren C , Tu Q , He J . Fabrication of pH-responsive temozolomide (TMZ)-clacked tannic acid-altered zeolite imidazole nanoframeworks (ZIF-8) enhance anticancer activity and apoptosis induction in glioma cancer cells [J]. J Biomater Sci Polym Ed , 2024 , 35 ( 13 ): 1978 - 1998 . doi: 10.1080/09205063.2024.2364533 http://dx.doi.org/10.1080/09205063.2024.2364533 .
Babaei G , Aziz SG , Jaghi NZZ . EMT,cancer stem cells and autophagy; the three main axes of metastasis [J]. Biomed Pharmacother , 2021 , 133 ( 1 ): 110909 - 110919 . doi: 10.1016/j.biopha.2020.110909 http://dx.doi.org/10.1016/j.biopha.2020.110909 .
Saitoh M . Transcriptional regulation of EMT transcription factors in cancer [J]. Semin Cancer Biol , 2023 , 97 ( 1 ): 21 - 29 . doi: 10.1016/j.semcancer.2023.10.001 http://dx.doi.org/10.1016/j.semcancer.2023.10.001 .
Nan Y , Guo L , Lu Y , et al . miR-451 suppresses EMT and metastasis in glioma cells [J]. Cell Cycle , 2021 , 20 ( 13 ): 1270 - 1278 . doi: 10.1080/15384101.2021.1933303 http://dx.doi.org/10.1080/15384101.2021.1933303 .
Wang W , Hao Y , Zhang A , et al . miR-19a/b promote EMT and proliferation in glioma cells via SEPT7-AKT-NF-κB pathway [J]. Mol Ther Oncolytics , 2021 , 20 ( 1 ): 290 - 305 . doi: 10.1016/j.omto. 2021.01.005 http://dx.doi.org/10.1016/j.omto.2021.01.005 .
Xiu MX , Liu YM , Kuang BH . The oncogenic role of Jagged1/Notch signaling in cancer [J]. Biomed Pharmacother , 2020 , 129 ( 1 ): 110416 - 110426 . doi: 10.1016/j.biopha.2020.110416 http://dx.doi.org/10.1016/j.biopha.2020.110416 .
Ham SW , Kim JY , Seo S , et al . Annexin A2 stabilizes oncogenic JAG1 intracellular domain by inhibiting proteasomal degradation in glioblastoma cells [J]. Int J Mol Sci , 2023 , 24 ( 19 ): 14776 - 14790 . doi: 10.3390/ijms241914776 http://dx.doi.org/10.3390/ijms241914776 .
Shi B , Ge F , Cai L , et al . Significance of NotchScore and JAG1 in predicting prognosis and immune response of low-grade glioma [J]. Front Immunol , 2023 , 14 ( 1 ): 1247288 - 1247298 . doi: 10.3389/fimmu.2023.1247288 http://dx.doi.org/10.3389/fimmu.2023.1247288 .
0
Views
4
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
